Skip to content

Pulse Biosciences, Inc. PLSE Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

LivaNova logo
LivaNovaLIVN
$14.29M+32.4%
AtriCure logo
AtriCureATRC
Medtronic logo
MedtronicMDT
Merit Medical Systems logo
Merit Medical SystemsMMSI
Bausch Health Companies logo
Bausch Health CompaniesBHC

Other financials

Income statement

See full
Revenue$401.0K
Gross profit$31.0K
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%
EPS (diluted)-$0.49-2.1%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation

See full
Market cap$1.77B+38.4%

Profitability

See full
Gross margin-4,067.5%
Operating margin-10,392.1%
Net margin-9,929%
FCF margin-7,390%

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment?
Pulse Biosciences, Inc. (PLSE) reported payments to acquire property, plant, and equipment of $33K in Q1 2026.
How has Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment changed year-over-year?
Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment decreased by 26.7% year-over-year, from $45K to $33K.
What is the long-term trend for Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s payments to acquire property, plant, and equipment has grown at a -7.9% compound annual growth rate (CAGR), from $437K to $315K.